tiprankstipranks
Trending News
More News >
VITA 34 AG (DE:V3V)
XETRA:V3V
Advertisement

VITA 34 (V3V) Price & Analysis

Compare
0 Followers

V3V Stock Chart & Stats


V3V FAQ

What was VITA 34 AG’s price range in the past 12 months?
VITA 34 AG lowest stock price was €3.70 and its highest was €7.65 in the past 12 months.
    What is VITA 34 AG’s market cap?
    VITA 34 AG’s market cap is €119.41M.
      When is VITA 34 AG’s upcoming earnings report date?
      VITA 34 AG’s upcoming earnings report date is Nov 21, 2025 which is in 75 days.
        How were VITA 34 AG’s earnings last quarter?
        VITA 34 AG released its earnings results on Aug 27, 2025. The company reported €0.038 earnings per share for the quarter, beating the consensus estimate of N/A by €0.038.
          Is VITA 34 AG overvalued?
          According to Wall Street analysts VITA 34 AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does VITA 34 AG pay dividends?
            VITA 34 AG pays a Annually dividend of €0.16 which represents an annual dividend yield of N/A. See more information on VITA 34 AG dividends here
              What is VITA 34 AG’s EPS estimate?
              VITA 34 AG’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does VITA 34 AG have?
              VITA 34 AG has 17,640,104 shares outstanding.
                What happened to VITA 34 AG’s price movement after its last earnings report?
                VITA 34 AG reported an EPS of €0.038 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 12.403%.
                  Which hedge fund is a major shareholder of VITA 34 AG?
                  Currently, no hedge funds are holding shares in DE:V3V

                  VITA 34 Stock Smart Score

                  Company Description

                  VITA 34 AG

                  VITA 34 (V3V) is a leading company in the field of stem cell banking and regenerative medicine, specializing in the collection, processing, and storage of stem cells derived from umbilical cord blood and tissue. The company operates primarily in the healthcare sector, offering its services to expectant parents and healthcare providers. VITA 34's core products include private and public stem cell storage solutions, as well as related services that support the use of stem cells in medical treatments and research.

                  VITA 34 (V3V) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  MATERNUS-Kliniken AG
                  Limes Schlosskliniken AG
                  HAEMATO AG
                  Gesundheitswelt Chiemgau AG
                  MPH Health Care AG
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis